Bind Therapeutics files papers for IPO: www.fiercebiotech.com/story/langers-bind-files-80m-ipo-new-biotech-offerings-go-gangbusters/2013-08-12PSMA-targeted docetaxel sounds like a meh lead program though they do have AMGN, PFE, and AZN as big name partners for earlier-stage programs: http://bindtherapeutics.com/pipeline/pipeline.html .